Code | 6263C | ||||||||||
MA number | EU/1/06/356/022 | ||||||||||
Product Form: | gra sac 30x360 mg (vre.PET/Al/PE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 10.11.2017 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | EXJADE_Kontrolny zoznam pre lekara.pdf |
Dokument: | EXJADE_Prirucka pre lekarov.pdf |
Dokument: | EXJADE_Prirucka pre pacienta.pdf |
Safety feature | Yes |
Data update: | 18.06.2018 |